450 related articles for article (PubMed ID: 24217582)
1. Emerging cell and cytokine targets in rheumatoid arthritis.
Burmester GR; Feist E; Dörner T
Nat Rev Rheumatol; 2014 Feb; 10(2):77-88. PubMed ID: 24217582
[TBL] [Abstract][Full Text] [Related]
2. Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy.
Alam J; Jantan I; Bukhari SNA
Biomed Pharmacother; 2017 Aug; 92():615-633. PubMed ID: 28582758
[TBL] [Abstract][Full Text] [Related]
3. [Interleukins network in rheumatoid arthritis pathophysiology: beyond proinflammatory cytokines].
Sánchez-Ramón S; López-Longo FJ; Carreño L
Reumatol Clin; 2011 Mar; 6S3():S20-4. PubMed ID: 21794767
[TBL] [Abstract][Full Text] [Related]
4. Emerging targets of biologic therapies for rheumatoid arthritis.
Tarner IH; Müller-Ladner U; Gay S
Nat Clin Pract Rheumatol; 2007 Jun; 3(6):336-45. PubMed ID: 17538565
[TBL] [Abstract][Full Text] [Related]
5. B Lymphocytes in Rheumatoid Arthritis and the Effects of Anti-TNF-α Agents on B Lymphocytes: A Review of the Literature.
Pala O; Diaz A; Blomberg BB; Frasca D
Clin Ther; 2018 Jun; 40(6):1034-1045. PubMed ID: 29801753
[TBL] [Abstract][Full Text] [Related]
6. Treatment of rheumatoid arthritis with biological agents - as a typical and common immune-mediated inflammatory disease.
Takeuchi T
Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(8):600-608. PubMed ID: 29021510
[TBL] [Abstract][Full Text] [Related]
7. Emerging therapeutics for rheumatoid arthritis.
Bingham CO
Bull NYU Hosp Jt Dis; 2008; 66(3):210-5. PubMed ID: 18937634
[TBL] [Abstract][Full Text] [Related]
8. Selected cytokine pathways in rheumatoid arthritis.
Noack M; Miossec P
Semin Immunopathol; 2017 Jun; 39(4):365-383. PubMed ID: 28213794
[TBL] [Abstract][Full Text] [Related]
9. Biological agents in rheumatoid arthritis.
Shankar S; Handa R
J Postgrad Med; 2004; 50(4):293-9. PubMed ID: 15623977
[TBL] [Abstract][Full Text] [Related]
10. Effects of antirheumatic agents on cytokines.
Barrera P; Boerbooms AM; van de Putte LB; van der Meer JW
Semin Arthritis Rheum; 1996 Feb; 25(4):234-53. PubMed ID: 8834013
[TBL] [Abstract][Full Text] [Related]
11. Cytokine networks--towards new therapies for rheumatoid arthritis.
McInnes IB; Liew FY
Nat Clin Pract Rheumatol; 2005 Nov; 1(1):31-9. PubMed ID: 16932625
[TBL] [Abstract][Full Text] [Related]
12. B-cell-directed therapies for autoimmune disease.
Dörner T; Radbruch A; Burmester GR
Nat Rev Rheumatol; 2009 Aug; 5(8):433-41. PubMed ID: 19581902
[TBL] [Abstract][Full Text] [Related]
13. Translating basic research into clinical rheumatology.
van der Woude D; Huizinga TW
Best Pract Res Clin Rheumatol; 2008 Apr; 22(2):299-310. PubMed ID: 18455686
[TBL] [Abstract][Full Text] [Related]
14. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.
Liu W; Zhang Y; Zhu W; Ma C; Ruan J; Long H; Wang Y
Front Immunol; 2018; 9():2228. PubMed ID: 30319663
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety implications of molecular constructs of biological agents for rheumatoid arthritis.
Timlin H; Bingham CO
Expert Opin Biol Ther; 2014 Jul; 14(7):893-904. PubMed ID: 24720727
[TBL] [Abstract][Full Text] [Related]
16. Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic Lupus.
Cohen S; Clowse M; Pardo P; Bhattacharya I; Menon S; Gourley I; Diehl A
Clin Ther; 2016 Jun; 38(6):1417-1434.e2. PubMed ID: 27112532
[TBL] [Abstract][Full Text] [Related]
17. In vitro effects of 2 antirheumatic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis.
Ounissi-Benkalha H; Pelletier JP; Tardif G; Mineau F; Jolicoeur FC; Ranger P; Martel-Pelletier J
J Rheumatol; 1996 Jan; 23(1):16-23. PubMed ID: 8838503
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-18: a therapeutic target in rheumatoid arthritis?
McInnes IB; Liew FY; Gracie JA
Arthritis Res Ther; 2005; 7(1):38-41. PubMed ID: 15642152
[TBL] [Abstract][Full Text] [Related]
19. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
Christodoulou C; Choy EH
Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339
[TBL] [Abstract][Full Text] [Related]
20. Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction.
Boissier MC; Semerano L; Challal S; Saidenberg-Kermanac'h N; Falgarone G
J Autoimmun; 2012 Sep; 39(3):222-8. PubMed ID: 22704962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
